Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$5.78 - $7.33 $3,468 - $4,398
600 New
600 $3,000
Q3 2022

Nov 09, 2022

SELL
$7.55 - $11.25 $136,353 - $203,175
-18,060 Reduced 64.36%
10,000 $84,000
Q2 2022

Aug 17, 2022

SELL
$6.8 - $14.23 $1.38 Million - $2.88 Million
-202,405 Reduced 87.82%
28,060 $212,000
Q1 2022

May 16, 2022

SELL
$13.42 - $23.38 $195,932 - $341,348
-14,600 Reduced 5.96%
230,465 $3.19 Million
Q4 2021

Feb 15, 2022

BUY
$12.78 - $23.74 $127,800 - $237,399
10,000 Added 4.25%
245,065 $5.82 Million
Q3 2021

Nov 15, 2021

BUY
$11.73 - $16.08 $173,076 - $237,260
14,755 Added 6.7%
235,065 $3.1 Million
Q2 2021

Aug 17, 2021

BUY
$12.85 - $16.2 $1.22 Million - $1.53 Million
94,650 Added 75.32%
220,310 $3.42 Million
Q1 2021

May 17, 2021

BUY
$13.84 - $17.8 $1.74 Million - $2.24 Million
125,660 New
125,660 $1.81 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.